Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM8YXKW)

Drug Name

Dihydroxyaluminium Drug Info

Synonyms

(2-Aminoacetoxy)dihydroxyaluminum; Dihydroxyaluminium glycinate; Dihydroxyaluminum aminoacetate; 41354-48-7; Robalate; Prodexin; Hyperacid; Alilac; (Glycinato)dihydroxyaluminum; Alminate; (T-4)-(Glycinato-N,O)dihydroxyaluminum; Dihydroxyaluminum aminoacetate [USAN:USP]; C2H6AlNO4; Dihydroxoaluminium glycinat; Aluminum glycinate, AldrichCPR; DTXSID3044546; (Glycinato-N,O)dihydroxyaluminum; 51484-68-5 (proacid); MolPort-023-220-319; 13682-92-3 (Parent); (Glycinato)dihydroxyaluminum hydrate; EINECS 237-193-8; Aluminum, (glycinato-N

Indication

Disease Entry	ICD 11	Status	REF
Skin inflammation	EF20.Y	Approved	[1]

Therapeutic Class

Antiinflammatory Agents

Cross-matching ID

PubChem CID: 16683036
CAS Number: CAS 13682-92-3
TTD Drug ID: DM8YXKW

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Troponin C (TN-C)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Levosimendan	DMKBOS2	Congestive heart failure	BD10	Approved	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Troponin C (TN-C)	TT8RDXP	TNNC1_HUMAN	Stimulator	[2]

------------------------------------------------------------------------------------

References

1	Drug information of Dihydroxyaluminium, Health Canada, 2007.
2	A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med. 2009 Dec;9(4):303-12.
3	Timing of levosimendan in cardiac surgery. Anadolu Kardiyol Derg. 2009 Jun;9(3):223-30.